MedPath

Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging

Completed
Conditions
Epilepsy
Interventions
Radiation: 18F-FDG
Registration Number
NCT04725162
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

This retrospective study aimed to develop a new approach for automatic localization of epilepsy foci in children with epilepsy.

Detailed Description

This retrospective study aimed to develop a new approach for automatic localization of epilepsy foci in children with intractable epilepsy.

Pediatric patients with intractable epilepsy would be retrospectively included in this study. The inclusion criteria included (1) age between 6 and 18 y; (2) detailed seizure semiology evaluation, MRI, EEG and interictal 18F-FDG PET/CT examination; (3) clinical diagnosis as focal epilepsy. The exclusion criteria included (a) any history of central nervous system disease; (b) poor image quality due to head movement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
234
Inclusion Criteria
    1. age between 6 and 18 years.
    1. detailed presurgical evaluation, including seizure semiology evaluation, MRI, EEG and interictal 18F-FDG PET/Computer Tomography (CT) examination.
    1. clinical diagnosis as focal epilepsy.
Exclusion Criteria
    1. any history of central nervous system (CNS) disease such as trauma and CNS tumor.
    1. poor image quality due to head movement.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Epilepsy patients18F-FDGPediatric patients with focal epilepsy.
Validation18F-FDGChildren who underwent 18F-FDG PET/MRI to examine extracranial tumors.
Control18F-FDGAge-matched controls who underwent 18F-FDG PET/CT examination for diseases outside brains.
Primary Outcome Measures
NameTimeMethod
AccuracyThrough study completion, about 6 months

The accuracy of epilepsy focus localization.

KappaThrough study completion, about 6 months

The agreement between experiment result and clinical diagnosis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath